Spikevax. Made to evolve.
The virus that causes COVID-19 is constantly changing.1 So we've updated our vaccine.2
Available in a pre-filled syringe.
Spikevax comes frozen in a single dose of 0.5mL.2
Flexible storage on your terms.
Keep frozen up to the expiration date or thawed in the refrigerator for up to 60 days.2
New Season. New Shot.
Spikevax (COVID-19 Vaccine, mRNA) 2024-2025 Formula has been updated to protect against changing variants, like KP.2, following ACIP recommendation.
Approved for individuals 12 years of age and older.1
We're here to help!
Please contact us if you have any questions about ordering and product availability or to arrange an appointment with our field staff.
Ordering Spikevax is easyGet your vaccine supply for the season. We offer multiple ways to order.
Indication
SPIKEVAX (COVID-19 Vaccine, mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older.
Important Safety Information
Contraindications
Do not administer SPIKEVAX to individuals with a known history of severe allergic reaction (e.g., anaphylaxis) to any component of SPIKEVAX or to individuals who had a severe allergic reaction (e.g., anaphylaxis) following a previous dose of a Moderna COVID-19 vaccine.
Warnings and Precautions
- Management of Acute Allergic Reactions: Appropriate medical treatment must be immediately available to manage potential anaphylactic reactions following administration of SPIKEVAX.
- Myocarditis and Pericarditis: Postmarketing data demonstrate increased risks of myocarditis and pericarditis, particularly within the first week following vaccination. The observed risk is highest in males 18 through 24 years of age.
- Syncope (fainting): May occur in association with administration of injectable vaccines. Procedures should be in place to avoid injury from fainting.
- Altered Immunocompetence: Immunocompromised persons, including individuals receiving immunosuppressive therapy, may have a diminished immune response to SPIKEVAX.
- Limitations of Vaccine Effectiveness: SPIKEVAX may not protect all vaccine recipients.
Adverse Reactions
The most commonly reported (≥10%) adverse reactions following any dose in any indicated patient population were pain at the injection site, fatigue, headache, myalgia, chills, arthralgia, axillary swelling/tenderness, nausea/vomiting, and swelling at the injection site.
Reporting Adverse Events and Vaccine Administration Errors
To report suspected adverse reactions, contact ModernaTX, Inc. at 1-866-663-3762 or VAERS at 1-800-822-7967 or www.vaers.hhs.gov.
Please click for SPIKEVAX Full Prescribing Information.
Centers for Disease Control, "About COVID-19." Updated June 13, 2024. Accessed August 12, 2024. https://www.cdc.gov/covid/about/index.html
- Spikevax. Prescribing Information. ModernaTX, Inc; 2024.
Centers for Disease Control, "CDC Updates Vaccine Recommendations." Updated July 12, 2024. Accessed August 12, 2024. https://www.cdc.gov/ncird/whats-new/cdc-updates-vaccine-recommendations-july-2024.html
Stay up to date
Receive the latest information about all products from Moderna.
By submitting your information, you agree to Moderna's Terms and Conditions. You also acknowledge that your information will be processed in accordance with Moderna's Privacy Statement. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
© 2024 Moderna US-COV-2400030 08/2024